Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HiPRESS study of low-dose argipressin versus noradrenaline during CRS-HIPEC surgery
NL-OMON58782Phase 4Recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Jan 2025
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of vasopressin and norepinephrine in cancer (2 arms), sponsored by Netherlands Cancer Institute. Primary endpoint: Cumulative total intraoperative fluid administration. Started Jan 2025; status: recruiting.
02
Drugs
vasopressinnorepinephrine
03
Conditions
cancer
Beyond the preview
Go deeper on NL-OMON58782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58782.